MCTA — CHARMING MEDICAL LTD
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date.
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | — | — | — | — | — | — |
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 2 SEC-registered investment managers reported holding MCTA (CHARMING MEDICAL LTD) in their latest 13F filings, with a combined reported value of $948.55K across 35.00K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved -7.7%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of CHARMING MEDICAL LTD (MCTA) include UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, ranked by reported 13F value among the 3 institutional holders on this page.
MCTA is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 2 | 35.00K | $948.55K | +0.0% |
| Q2 2026 | 3 | 45.75K | $1.34M | -2.0% |
| Q1 2026 | 2 | 35.70K | $1.05M | -8.5% |
| Q4 2025 | 2 | 39.00K | $1.14M | — |
Over the 4 quarters shown, institutional share counts decreased 10% in aggregate (Q4 2025 → Q3 2026); the largest single-quarter swing was Q1 2026 (-8.5%).
Top Institutional Holders (Q3 2026) — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 24.25K | $711.83K | 0.00% | Hold | |
| 10.75K | $236.72K | 0.00% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 3 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 24.25K | $711.83K | 0.00% | Reduce | |
| 10.75K | $315.62K | 0.00% | New | |
| 10.75K | $315.62K | 0.00% | Hold |
Q1 2026 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 24.95K | $732.38K | 0.00% | Reduce | |
| 10.75K | $315.62K | 0.00% | Hold |
Q4 2025 — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 28.25K | $829.25K | 0.00% | New | |
| 10.75K | $315.62K | 0.00% | New |
New Positions (Q3 2026)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
- GEODE CAPITAL MANAGEMENT, LLC sold 10.75K sh · $315.62K
Fund Position History — shares by quarter (top 3 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|---|
| UBS Group AG | 24.25K | 24.25K | 24.95K | 28.25K |
| Geode Capital Management | 10.75K | 10.75K | 10.75K | 10.75K |
| GEODE CAPITAL MANAGEMENT, LLC | — | 10.75K | — | — |
FAQ
Which funds hold MCTA?
As of 2026-Q3, 2 institutional funds reported holding MCTA (CHARMING MEDICAL LTD) in SEC 13F filings, with a combined reported value of $948.55K.
How many shares of MCTA do institutions own?
13F filers reported 35.00K shares of MCTA, worth $948.55K in aggregate at the end of 2026-Q3.
Is institutional ownership of MCTA rising or falling?
Share counts moved +0.0% versus the prior quarter — accumulation.
Who are the top institutional holders of MCTA?
The largest 13F holders are UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management; the top 25 are ranked at the top of this page.
Who are the major shareholders of CHARMING MEDICAL LTD?
The major shareholders of CHARMING MEDICAL LTD (MCTA) by reported 13F value are UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, Geode Capital Management, among 3 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.